Recent Finacing
Recent Raise
Chroma Medicine develops modular epigenetic editors that durably silence, activate, or multiplex gene expression in a single-dose platform without altering DNA sequence for monogenic and complex diseases.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Chroma Medicine.
